Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2004 1
2006 1
2008 1
2009 1
2011 2
2015 2
2016 1
2018 1
2022 1
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome.
Chan EY, Sinha A, Yu ELM, Akhtar N, Angeletti A, Bagga A, Banerjee S, Boyer O, Chan CY, Francis A, Ghiggeri GM, Hamada R, Hari P, Hooman N, Hopf LS, I MI, Ijaz I, Ivanov DD, Kalra S, Kang HG, Lucchetti L, Lugani F, Ma AL, Morello W, Camargo Muñiz MD, Pradhan SK, Prikhodina L, Raafat RH, Sinha R, Teo S, Tomari K, Vivarelli M, Webb H, Yap HK, Yap DY, Tullus K. Chan EY, et al. Among authors: raafat rh. Kidney Int. 2024 Dec;106(6):1146-1157. doi: 10.1016/j.kint.2024.09.011. Epub 2024 Oct 10. Kidney Int. 2024. PMID: 39395629 Free article.
Herding in humans.
Raafat RM, Chater N, Frith C. Raafat RM, et al. Trends Cogn Sci. 2009 Oct;13(10):420-8. doi: 10.1016/j.tics.2009.08.002. Epub 2009 Sep 11. Trends Cogn Sci. 2009. PMID: 19748818 Review.
Corrigendum to "Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats" [Int. Immunopharmacol. 124(Part A) (2023) 110945].
Raafat RS, Habib MZ, AbdElfattah AA, Olama NK, Abdelraouf SM, Hendawy N, Kamal KA, Nawishy SA, Aboul-Fotouh S. Raafat RS, et al. Int Immunopharmacol. 2023 Dec;125(Pt B):111203. doi: 10.1016/j.intimp.2023.111203. Epub 2023 Nov 15. Int Immunopharmacol. 2023. PMID: 37978013 No abstract available.
Corrigendum to "The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2021;100:225-237.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Kidney Int. 2023 Jul;104(1):205. doi: 10.1016/j.kint.2023.04.010. Kidney Int. 2023. PMID: 37349053 Free article. No abstract available.
15 results